IDVOther than small business
BOA (single-award IDV) 75N95018G00019SRI INTERNATIONAL
Overview
Award facts
- Obligated on orders under this IDV
- $5.28M
- $5,280,914 across 6 orders
- Period of performance
- From Sep 7, 2018
- Modifications
- 10
- Latest action Jul 17, 2024
- Contract type
- BOA (single-award IDV)
- PIID 75N95018G00019
Description of requirement
IGF::OT::IGF PURPOSE TO AWARD THE CONTRACT FOR TOXICOLOGICAL EVALUATIONS OF POTENTIAL MEDICATIONS, PERIOD OF PERFORMANCE: 09/07/2018- 09/06/2023. NIDA REF. NO. N01DA-18-8939
Dates and value
- Award date
- Signed on Sep 7, 2018
- Ordering period ends
- Sep 6, 2023
- Ceiling
- Ceiling (single-award vehicle): $9,750,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 17, 2024. View on USAspending · Recipient on SAM.gov
Recipient
LocationMENLO PARK, CA
UEISRG2J1WS9X63
CAGE code03652
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companySRI INTERNATIONAL
Business types and certifications
Nonprofit organizationTax-exempt corporation
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
Classification and competition
Classification
- Product or service (PSC)
- AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)
Competition
- Set-aside
- Not reported
- Contract pricing
- Order dependent (IDV allows pricing arrangement to be determined separately for each order)1
Solicitation and notices
- Solicitation ID
- NIHDA201800011
- Notices
- Award Notice posted Sep 10, 2018
- Solicitation posted Mar 29, 2018
- Presolicitation posted Mar 13, 2018
- Presolicitation posted Mar 13, 2018
- Presolicitation posted Mar 13, 2018
- Presolicitation posted Feb 9, 2018
- Sources Sought posted Dec 4, 2017
Contract details
- Major program
- Toxicological evaluations of potential medications
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 7, 2018
- Latest action
- Jul 17, 2024 — Other administrative actionModification P00010; administrative: no change in scope or value
- Latest substantive action
- Oct 19, 2021 — Change orderModification P00005
- Actions by type
- Base award1
- Other administrative action9
- Change order1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
Structure
- Award or IDV
- IDV
- IDV type
- BOAD
- Multiple or single award
- Single awardS
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N950
- Transactions recorded under this award key
- 11
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N950